GENE.00025 Proteogenomic Testing for the Evaluation of Malignancies Form
Procedure is not covered
This document addresses proteogenomic testing for the evaluation of malignancies in individuals who have been diagnosed with cancer.
Proteogenomic tests include, but may not be limited to:
- DarwinOncoTarget™ (Darwin Health, New York, NY)
- Genomic Proteomic Spectrometry, or GPS Cancer™ test (NantHealth, Culver City, CA)
Position Statement
Investigational and Not Medically Necessary:
Proteogenomic testing is considered investigational and not medically necessary for all indications.
Book a walkthrough
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.
Loading available demo times